Top Markets
Coin of the day
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Rangering i aksjer #32153
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Aksjekurs
$0.05504527
Sist synkronisert: 2026-08-17
Markedsverdi
$10.89M
Endring (1 dag)
15.38%
Endring (1 år)
-10.64%
Land
CA
Handel Hemostemix Inc. (HEM)

Kategori

Historikk for aksjesplitt for Hemostemix Inc. (HEM)
Aksjen Hemostemix Inc. (symbol: HEM) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 18, 2026.
Én HEM-aksje kjøpt før Aug 18, 2026 tilsvarer i dag 0 HEM-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR